Tech Company Financing Transactions

Peptimmune Funding Round

Covera Ventures, MPM Capital and New Enterprise Associates participated in a $8.9 million Series D funding round for Peptimmune. The round was announced on 7/16/2008.

Transaction Overview

Company Name
Announced On
7/16/2008
Transaction Type
Venture Equity
Amount
$8,900,000
Round
Series D
Proceeds Purpose
The proceeds of the financing are primarily being used to advance clinical development of Peptimmune's PI-2301 for the treatment of multiple sclerosis.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
64 Sidney Street 380
Cambridge, MA 02139
USA
Email Address
Overview
Peptimmune is a clinical stage biotechnology company that is utilizing both novel and proven technologies to improve the therapeutic management of chronic autoimmune and metabolic disorders.
Profile
Peptimmune LinkedIn Company Profile
Social Media
Peptimmune Company Twitter Account
Company News
Peptimmune News
Facebook
Peptimmune on Facebook
YouTube
Peptimmune on YouTube

Management Team

Title
Name
Email & Social
Chairman
Fredric Price
  Fredric Price LinkedIn Profile  Fredric Price Twitter Account  Fredric Price News  Fredric Price on Facebook
Chief Executive Officer
Thomas Mathers
  Thomas Mathers LinkedIn Profile  Thomas Mathers Twitter Account  Thomas Mathers News  Thomas Mathers on Facebook
VP - R & D
Eric Zanelli
  Eric  Zanelli LinkedIn Profile  Eric  Zanelli Twitter Account  Eric  Zanelli News  Eric  Zanelli on Facebook
VP - Regulatory Affairs
Uday Patel
  Uday Patel LinkedIn Profile  Uday Patel Twitter Account  Uday Patel News  Uday Patel on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/16/2008: BestOfMedia venture capital transaction
Next: 7/16/2008: Sojern venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary